Thermodynamic optimisation in drug discovery: a case study using carbonic anhydrase inhibitors
about
Carbonic anhydrase inhibitors: X-ray crystallographic studies for the binding of N-substituted benzenesulfonamides to human isoform II4-amino-substituted benzenesulfonamides as inhibitors of human carbonic anhydrasesFunctionalization of fluorinated benzenesulfonamides and their inhibitory properties toward carbonic anhydrasesComputational Calorimetry: High-Precision Calculation of Host-Guest Binding ThermodynamicsImproving MM-GB/SA Scoring through the Application of the Variable Dielectric Model.Survey of the year 2009: applications of isothermal titration calorimetry.Thermodynamic studies for drug design and screening.The impact of binding thermodynamics on medicinal chemistry optimizations.Compound Design by Fragment-Linking.Hydroxylamine-O-sulfonamide is a versatile lead compound for the development of carbonic anhydrase inhibitors.Binding affinity of substituted ureido-benzenesulfonamide ligands to the carbonic anhydrase receptor: a theoretical study of enzyme inhibition.Carbon- versus sulphur-based zinc binding groups for carbonic anhydrase inhibitors?Intrinsic Thermodynamics and Structures of 2,4- and 3,4-Substituted Fluorinated Benzenesulfonamides Binding to Carbonic Anhydrases.Connecting Classical QSAR and LERE Analyses Using Modern Molecular Calculations, LERE-QSAR (VI): Hydrolysis of Substituted Hippuric Acid Phenyl Esters by Trypsin.Thermodynamic Profiling of Carbonic Anhydrase Inhibitors
P2860
Q27674538-87576E84-74BB-4B6A-AAC4-9A42172A4A5BQ27695739-E9420949-D45D-4A8F-B559-CBE71613B569Q27698200-2DA35B78-3810-4E53-81C3-9D78C047C552Q30670127-9154448F-FBB8-4D74-959D-7BC76398A021Q35955749-34E3D198-DCC7-456B-8DC7-B45D120F1C1FQ37820930-BCFC4463-3B24-4824-8233-F6A8CFC5072BQ37998087-E6B37CEA-4094-4342-8458-3E0D7237AE77Q38542936-687DDC43-C626-4CB9-9632-C420872CE5ADQ38910944-6A35EAEF-361E-41B8-A8DF-2BCB21E9B35AQ40815863-C571FF91-DAB0-458C-9C7A-EC151FD04F11Q43519643-192BC66F-1FA5-4999-8957-6B4FDFD6A509Q47692161-79302746-E59F-44F4-9726-47947564C416Q48130089-D2CE45C8-3450-4161-8BEB-5BE5F0F7C228Q53749950-30D9EE19-66CA-474B-9473-CE30DE2F320AQ58293116-3CE41AF5-2470-439E-9E65-1797C45595EF
P2860
Thermodynamic optimisation in drug discovery: a case study using carbonic anhydrase inhibitors
description
2009 nî lūn-bûn
@nan
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Thermodynamic optimisation in ...... carbonic anhydrase inhibitors
@ast
Thermodynamic optimisation in ...... carbonic anhydrase inhibitors
@en
Thermodynamic optimisation in ...... carbonic anhydrase inhibitors
@nl
type
label
Thermodynamic optimisation in ...... carbonic anhydrase inhibitors
@ast
Thermodynamic optimisation in ...... carbonic anhydrase inhibitors
@en
Thermodynamic optimisation in ...... carbonic anhydrase inhibitors
@nl
prefLabel
Thermodynamic optimisation in ...... carbonic anhydrase inhibitors
@ast
Thermodynamic optimisation in ...... carbonic anhydrase inhibitors
@en
Thermodynamic optimisation in ...... carbonic anhydrase inhibitors
@nl
P2093
P2860
P356
P1433
P1476
Thermodynamic optimisation in ...... carbonic anhydrase inhibitors
@en
P2093
Alexander Alex
Amy Randall
Andrew Bent
Andrew D Scott
Chris Phillips
Luminita Damian
Maria Flocco
Ronan O'Brien
P2860
P304
P356
10.1002/CMDC.200900386
P50
P577
2009-12-01T00:00:00Z